Genomica Prices IPO, Hopes to raise $122M | GenomeWeb

NEW YORK, Sept 29 – Bioinformatics company Genomica (Nasdaq: GNOM) said Friday it had priced its initial public offering of 6,440,000 shares of common stock on the Nasdaq at $19.00 per share.

Gross proceeds from the offering, the latest in a string of bioinformatics IPOs, are expected to be $122.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.